TMCnet News
Mercato Partners Joins Series B Funding of KalderosSALT LAKE CITY, June 15, 2020 /PRNewswire/ -- Mercato Partners today announced participation in the $28 million series B financing of Kalderos, led by Bain Capital Ventures. Mercato Partners led the initial $7 million series A funding of Kalderos in 2019. With the goal of eliminating noncompliance from drug discount coordination, Kalderos has built the only real-time, compliant, point-of-sale chargeback solution for the prescription drug market. Combining industry expertise, data science, and comprehensive, deep-data libraries, Kalderos identifies previously undetected errors, ensuring the right discounts are applied to the right transaction. "Industry figures highlight the level of waste in the drug discount marketplace, with $8.5B in non-compliant drug discount claims in 2018 alone," said Micah Litow, President and COO of Kalderos. "In an era of ever-rising healthcare expenses, these noncompliant drug discounts do not benefit the patients they are intended to help and are inconsistent with our need for a sustainable healthcare system. We help providers, payers and drug manufacturers spend more time improving patients' lives and less time addressing drug discount compliance. We are grateful our original investor, Mercato Partners, returned to support this series B round led by Bain Capital Ventures." Founded i 2016, Kalderos released its first SaaS platform that detects problems in the complex financial interplay between pharmacies, insurers, manufacturers and payers. Current customers include nearly half of the 15 largest drug manufacturers. "Since our initial series A investment, we have been very pleased with the progress Kalderos has made executing its timely and compelling vision to eliminate noncompliance and inefficiency in the U.S. healthcare system," said Joe Kaiser, Director at Mercato Partners. "With this new round of funding, the excellent team at Kalderos will be able to grow their footprint to ensure drug discount programs finally work as intended on behalf of patients. The company's data-driven, objective approach to drug discount management has real momentum and is redefining how the business of healthcare performs." About Mercato Partners About Kalderos View original content:http://www.prnewswire.com/news-releases/mercato-partners-joins-series-b-funding-of-kalderos-301076943.html SOURCE Mercato Partners |